Luye Pharma Group Ownership
HK$1.75
2.65%
Hong Kong, Sep 18, 04:00 pm HKT.
Closed.
ISIN
BMG570071099
Symbol
2186
Industry
Luye Pharma Group Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Luye Life Sciences Group Ltd.
|
1.246b | 31.20% | — | Sep 10 2025 |
| 2 |
Hillhouse Investment Management Limited
|
552.324m | 13.83% | — | Sep 10 2025 |
| 3 |
GF Fund Management Co., Ltd.
|
73.092m | 1.83% | +21.535m | Dec 31 2025 |
| 4 |
China Universal Asset Management Co., Ltd.
|
63.260m | 1.58% | +21.962m | Dec 31 2025 |
| 5 |
RRJ Management (HK) Ltd.
|
52.994m | 1.33% | -28.319m | Sep 08 2025 |
|
1
Luye Life Sciences Group Ltd.
|
31.20%
1.246b
|
|
2
Hillhouse Investment Management Limited
|
13.83%
552.324m
|
|
3
GF Fund Management Co., Ltd.
|
1.83%
73.092m
|
|
4
China Universal Asset Management Co., Ltd.
|
1.58%
63.260m
|
|
5
RRJ Management (HK) Ltd.
|
1.33%
52.994m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 49.76% of Luye Pharma Group, with Luye Life Sciences Group Ltd. the biggest at 31.20%, followed by Hillhouse Investment Management Limited (13.83%) and GF Fund Management Co., Ltd. (1.83%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
